Compare Vaxcyte Inc. Common Stock (PCVX) vs Procter & Gamble Co (PG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vaxcyte Inc. Common Stock vs Procter & Gamble Co — how do they compare? Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B), while Procter & Gamble Co trades at $157.69 (market cap $355.46B). The key difference: Procter & Gamble Co is far larger — about 33.8× Vaxcyte Inc. Common Stock's market cap, and Procter & Gamble Co pays a 2.85% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and Procter & Gamble Co for 132 Days on average.
| PCVX | PG | |
|---|---|---|
Market Cap | $10.51B | $355.46B |
Volume | 2,644,694 | 5,731,171 |
Sector | Health | Consumer Staples |
52-Week High | $73.82 | $167.18 |
52-Week Low | $40.32 | $138.10 |
Typical Hold Time | 0 Days | 132 Days |
Enterprise Value | $9.14B | $381.30B |
Dividend Yield | — | 2.85% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Procter & Gamble (PG) trades at $156.57, up 2.2% today, near its consensus price target of $160.13. The stock shows bullish technical signals with strong moving average support and has beaten earnings estimates for three consecutive quarters. Revenue reached $84.28B in 2025 with a net income margin of 18.44%, while the company maintains a robust dividend history and positive cash flow trends.
PG offers stable growth with high profitability and shareholder returns, but premium valuation multiples pose near-term upside limitations. Risks include soft demand outlook and competitive pressures, though analyst consensus remains bullish with 53% buy ratings. The stock's resilience in volatile markets supports its appeal for dividend-focused investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →About Procter & Gamble Co
The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →
